Companies / Sundance Biosciences
Sundance Biosciences
South San Francisco, United States
Sundance Biosciences is developing oral therapies targeting TYK2, an enzyme that plays an important role in regulating the immune system.
Sundance Biosciences, based in South San Francisco, United States, has 2 investors on file, among them Agent Capital and Westlake BioPartners. Its site was last checked 13 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Agent Capital
35 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (87%), AI & Machine Learning (8%), Enterprise Software (5%).
More from Westlake BioPartners
15 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See Westlake BioPartners' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Sundance Biosciences and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Agent Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/sundancebio.com/investors
# also
GET /v1/companies/sundancebio.com
GET /v1/companies/sundancebio.com/news